Pro-Dex, Inc. (PDEX)
Nasdaq · Healthcare · Medical Instruments & Supplies
$65.41+2.08%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $210M
- P/E (trailing)
- 15.9
- Forward P/E
- 19.5
- 52-week range
- $23.47 – $77.00
- 52-week change
- +89.33%
- EPS (trailing)
- $4.12
- Next earnings
- Oct 29, 2026
Fiscal year to Jun 2026
- Revenue
- $77.5M (+16.45%)
- Net income
- $13.7M
- Operating margin
- 16.8%
- Diluted EPS
- $4.12
- Free cash flow
- $6.8M
From the company’s annual report on SEC EDGAR.
About Pro-Dex, Inc.
Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; manufactures and sells rotary air motors to various industries; and precision machined parts and assemblies for the aerospace and defense industries. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
Headquarters: Irvine, United States · 201 employees · pro-dex.com